Drug Type ASO |
Synonyms FGFRRx, IONIS FGFR4RX, ISIS-FGFR4RX + [4] |
Target |
Action antagonists |
Mechanism FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |


| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Phase 2 | United States | 01 Jun 2015 |





